PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 660 of 764

Advanced search
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Toxicity of dolutegravir and evaluation of doravirine for alternative 1st line antiretroviral treatment in people living with HIV

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Enhanced preventive antiparasitic treatment for better health of African pregnants and their babies

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Zacks Investment ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics Starts Human Clinical Trials For New Obesity Drug Following Federal Regulatory Clearance

TIKR.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Botulism: diagnosis, data and analysis

The symptoms and epidemiology of botulism.

UK Health Security AgencyOriginal source
🌍Industryinvestors.vivani.comTier 1 · Company source

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani MedicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Has the Wrong Mission. That’s Why It Fails.

Real Clear PoliticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Krystal Biotech, Inc. – NASDAQ:KRYS

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

As compounding pharmacies expand, patients are left in the dark about drug risks

Houston ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Q&A: The Reason Behind Lilly's Pennsylvania Facility

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Atea Pharmaceuticals Completes Patient Enrollment in Phase

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eledon trial will use Natera’s Prospera test to track kidney rejection

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Atea enrolls 880-plus patients in global hepatitis C trial

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial

Business WireOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Ionis bags $30M from Recordati for ex-US rights to near-approval rare disease prospect

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Implementing reporter assay-based MAT for rapid pyrogen detection

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ADC Therapeutics cuts jobs as Zynlonta FDA talks loom

The PharmaletterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Julie Kim takes top job at Takeda after Weber retirement

The PharmaletterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hotels, restaurants must provide free water, says Maharashtra FDA; issues comprehensive order on food safety

ET HospitalityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The realities of pharmaceutical onshoring: a CDMO perspective

Cleanroom TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma (HELP) prices US$50M share sale to fund Phase 3 MDD trial

Stock TitanOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

Adding and configuring a Card

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Highs and Lows: U.S. Drug Prices in 2025

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Remix to enter Nasdaq through Passage Bio reverse merger

The PharmaletterOriginal source
🌍Industrysinopharmtech.comTier 1 · Company source

Sinopharmtech at Baltic Veterinary Forum 2026

Sinopharm TechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[BIO USA] ABL Bio CEO Sanghoon Lee: "Phase 3 Gastric Cancer Drug Trial to Begin This Year"

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Yomiuri: Takeda Pharmaceutical's Weber Says Company in 'Good Position for the Future' As He Steps Down

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of RTW Biotech Opportunities Ltd USD – FWB:0BM

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of BioMarin Pharmaceutical Inc. – GETTEX:BM8

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Feng Chi Biotech Corp. – TPEX:6744

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Krystal Biotech, Inc. – NASDAQ:KRYS

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The biotech founder asking why good science gets stuck

UNSW SydneyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tracking Cathie Wood: Major AI Biotech Discovery Bet on Recursion, Heavy Reduction in Absci Holdings

MoomooOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BIO 2026: How NIH cuts have threatened US competitiveness against China

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd. $TEVA Stake Increased by SG Americas Securities LLC

MarketBeatOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BIO 2026: Indiana, biopharma investment and the Lilly effect

Pharmaceutical TechnologyOriginal source
🇩🇰Regulatorylaegemiddelstyrelsen.dkTier 1 · Regulatory source

Are you working with cell therapy and planning a clinical trial?

Danish Medicines AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ABL Bio is launching phase 3 global clinical trials of its new gastric cancer drug "ABL111" within t..

매일경제Original source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Vaccine schedule change helps protect babies earlier against meningitis B

There has been good early uptake of chickenpox-containing MMRV, but a measles coverage gap persists...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Biosecure didn’t stop China’s rise in biotech. Some lawmakers want to do more

statnews.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hsbc Holdings PLC Lowers Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Pertussis: laboratory confirmed cases reported in England 2025

Laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Fungaemia (including candidaemia): annual data from voluntary surveillance

Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in Eng...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Epidemiology of COVID-19 in England

These reports summarise trends in the epidemiology of COVID-19 in England. Reports will be published...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Record HK delegation showcases life sciences edge in San Diego

chinadailyasia.comOriginal source
🇫🇷Regulatoryleem.orgTier 1 · Regulatory source

Baromètre 360° de l’attractivité de la France pour l’industrie pharmaceutique - Edition 2026 : Accès aux traitements, progrès thérapeutique, attractivité de la France : reprendre l’avantage ou décrocher ?

LEEM FranceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of BioMarin Pharmaceutical Inc. – NASDAQ:BMRN

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[BIO USA 2026] ABL Bio bets on Neok Bio to create US-Style value through later-stage clinical development

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can Restaurants Charge You For Drinking Water? Maharashtra FDA’s New Order Says…

curlytales.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

East Asia’s biotech autonomy push is already stunting innovation

Asia TimesOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

Cape Winelands Airport and SU forge strategic partnership for smart and sustainable development

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jazz Pharmaceuticals Zepzelca Misses Primary Endpoint in Phase 3 Lung Cancer Trial

sekbernews.idOriginal source
🇮🇹Industryrecordati.comTier 1 · Company source

RECORDATI ANNOUNCES LICENSE AGREEMENT WITH IONIS PHARMACEUTICALS FOR ZILGANERSEN FOR THE TREATMENT OF ALEXANDER DISEASE IN ALL COUNTRIES OUTSIDE THE U.S.

RecordatiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innovative Molecules Starts Phase 2a Trial of Adibelivir for Genital Herpes

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phathom Completes Enrollment in Phase 2 Vonoprazan EoE Trial Ahead of Schedule

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Backs Entera Bio’s Phase 3 Plan for Oral EB613 Osteoporosis Drug

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA bans serving food in newspapers, issues statewide food safety order

The Economic TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly signs new partnership deal with China's Abbisko

medwatch.comOriginal source